TRICARE Pharmacy Program RFI (Draft Section C & H)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

-

NAICS

524114 - Direct Health and Medical Insurance Carriers

Classification Code

Q201

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents3
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice as part of its acquisition planning for the forthcoming TRICARE Pharmacy Program (TPharm6) contract. This notice serves as a Request for Information (RFI) and is specifically aimed at soliciting industry feedback on two critical draft documents: Section C (Statement of Work) and Section H (Special Contract Requirements). The intent is to refine and enhance the program requirements and contractual framework for the next generation of the TRICARE Pharmacy Program, which provides pharmacy benefits to eligible military beneficiaries across the United States. The scope of this procurement encompasses the administration and management of pharmacy benefits under the TRICARE program, as indicated by the NAICS code 524114 (Direct Health and Medical Insurance Carriers) and Product Service Code Q201. The DHA is seeking input from qualified vendors with relevant experience in large-scale health and pharmacy benefit management, with the goal of ensuring that the final solicitation reflects industry best practices, operational feasibility, and the highest standards of beneficiary care. Key objectives of this RFI include gathering detailed industry insights on the draft Statement of Work and Special Contract Requirements. The DHA is particularly interested in identifying potential challenges, innovative solutions, and recommendations for improvement that will support the effective delivery of pharmacy services to TRICARE beneficiaries. The expected deliverables at this stage are comprehensive written comments, questions, and suggestions pertaining to the draft documents, which will inform the finalization of the solicitation package. To facilitate robust industry engagement, the DHA will host one-on-one meetings with interested vendors during the summer of 2026. These sessions are designed to provide a forum for in-depth discussion, clarification of requirements, and collaborative problem-solving. Vendors wishing to participate must submit their requests and any written feedback by May 11, 2026, at 12:00 PM Mountain Time. All correspondence should be directed to [email protected], with the company name and "Draft Documents Response" clearly indicated in the subject line. Requests for one-on-one meetings should be submitted via the provided online form. The place of performance for the anticipated contract is within the United States. The procurement is managed by the Defense Health Agency, with primary contacts Viktoria Reed ([email protected], 303-676-3648) and Brooke Wolfe ([email protected], 303-676-3799) available for further information. The notice remains active, and all relevant documents and updates can be accessed through the official SAM.gov opportunity page. This RFI does not constitute a formal solicitation or a commitment to award a contract; rather, it is a critical step in the DHA’s market research and acquisition planning process. Contractors with demonstrated capabilities in health insurance and pharmacy benefit administration are encouraged to review the draft documents and participate in this collaborative process to help shape the future of the TRICARE Pharmacy Program.